The Effect of Fibrates on Lowering Low-Density Lipoprotein Cholesterol and Cardiovascular Risk Reduction: A Systemic Review and Meta-analysis.

Treatment with fibrates was associated with decreased risk of MACE. The reduction in MACE risk with fibrate therapy appears to be attributable to LDL-C reduction rather than a decrease in triglyceride levels.